FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/12/2024
Voltar para busca
Dado oficial do USPTO
NEUTROCHECK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEUTROCHECK
ST13
US500000079357265Classe
5, 9, 10
Pedido
79357265
Registro
7410701
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
14/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
19/07/2022
Data de registro
11/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/06/2024
Última transação
11/06/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
52 North Health Limited
Representantes
John W. McGlynn RatnerPrestia
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic preparations and materials for medical purposes; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical use; medical diagnostic test strips for white blood cell analysis; reagents and media for medical and veterinary diagnostic purposes; reagents for use in medical diagnostic tests; diagnostic biomarker reagents for medical purposes; chemical preparations for testing blood for medical purposes; medical test kits comprising diagnostic testing materials for medical purposesmedical diagnostic reagents and medical diagnostic biomarker reagents; diagnostic testing materials for medical purposesmedical diagnostic reagents and medical diagnostic biomarker reagents; blood test kits comprising medical diagnostic testing materials for blood in the nature of medical diagnostic reagents and medical diagnostic biomarker reagents; white blood cell test kits comprising medical diagnostic testing materials for white blood cells in the nature of medical diagnostic reagents and medical diagnostic biomarker reagents; all of the foregoing excluding preparationsmaterialstest stripsreagents and media for use in blood glucose monitoring and diabetes care
Classe 9
Downloadable and recorded software for use in detection of white blood cells; downloadable and recorded mobile applications for use in detection of white blood cells
Classe 10
Medical and veterinary apparatus and instruments for monitoring blood properties; diagnosticexaminationmonitoring equipment for monitoring blood properties; medical devices for monitoring blood properties; blood testing apparatus and equipmentapparatus for taking blood samplesblood collection needlesblood collecting tubules; medical diagnostic testing apparatus for use in immunoassay procedures; medical test kits comprising diagnostic testing apparatus for monitoring blood properties; diagnostic testing apparatus for monitoring blood properties and for white blood cell analysis; blood test kits comprising blood testing apparatus for use in detection of white blood cells and for white blood cell analysis; blood test kits comprising blood testing apparatus for monitoring white blood cell levels; white blood cell test kits comprising white blood cell testing apparatus for monitoring white blood cell levels; all of the foregoing excluding preparationsmaterialstest stripsreagents and media for use in blood glucose monitoring and diabetes care
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/11/2024
FIMP
FINAL DISPOSITION PROCESSED
21/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/06/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
27/05/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
19/05/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/05/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/05/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/05/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
17/04/2024
APET
ASSIGNED TO PETITION STAFF
16/04/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/03/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
22/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/01/2024
PUBO
PUBLISHED FOR OPPOSITION
23/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
22/01/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/01/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/12/2023
RFNT
REFUSAL PROCESSED BY IB
11/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/06/2023
RFRR
REFUSAL PROCESSED BY MPU
19/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/05/2023
CNRT
NON-FINAL ACTION WRITTEN
12/05/2023
DOCK
ASSIGNED TO EXAMINER
04/05/2023
MAFR
APPLICATION FILING RECEIPT MAILED
13/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/12/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEUTROCHECK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.